CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Iohexol

碘海醇 杂质对照品Iohexol Impurities

EPUSP33 个杂质条目33 impurity entries

本页汇总 碘海醇 的 33 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 33 impurity reference standards of Iohexol with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 碘海醇(Iohexol)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesQuality by Design approach in the development of hydrophilic interaction liquid chromatographic method for the analysis of iohexol and its impurities
    Journal of pharmaceutical and biomedical analysis · 2015 · Jovanović M et al.  ·  PMID 25796982  ·  DOI
  2. 杂质研究Impurity studiesCytogenotoxic and Molecular Interaction Profile of Iohexol in SH-SY5Y Human Neuroblastoma Cells: An In Vitro and In Silico Approach
    Journal of applied toxicology : JAT · 2026 · Husunet MT  ·  PMID 41024663  ·  DOI
  3. 分析方法Analytical MethodsDevelopment and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method for the simultaneous determination of iohexol, p-aminohippuric acid and creatinine in porcine and broiler chicken plasma
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2019 · Dhondt L et al.  ·  PMID 31004849  ·  DOI
  4. 分析方法Analytical MethodsCorrigendum to "Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method for the simultaneous determination of iohexol, p-aminohippuric acid and creatinine in porcine and broiler chicken plasma" [J. Chromatogr. B 1117 (2019) 77-85]
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2019 · Dhondt L et al.  ·  PMID 31151834  ·  DOI
  5. 分析方法Analytical MethodsIohexol assay for direct determination of glomerular filtration rate: optimization and development of an HPLC-UV method for measurement in serum and urine
    Clinica chimica acta; international journal of clinical chemistry · 2020 · El Assri S et al.  ·  PMID 32416172  ·  DOI

碘海醇 —— 原料药与杂质对照品Iohexol — drug substance & impurities

共 33 个条目(含原料药本体)33 items incl. the drug substance
Iohexol Impurity 9(Iohexol EP Impurity I) structure
EPI
碘海醇杂质9(碘海醇EP杂质I)Iohexol Impurity 9(Iohexol EP Impurity I)
Iohexol Impurity 9(Iohexol EP Impurity I)
CAS No.196309-19-0
Chemical FormulaC17H23I2N3O8
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 10(Iohexol EP Impurity J) structure
EPJ
碘海醇杂质10(碘海醇EP杂质J)Iohexol Impurity 10(Iohexol EP Impurity J)
Iohexol Impurity 10(Iohexol EP Impurity J)
CAS No.76801-93-9
Chemical FormulaC14H18I3N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 11(Iohexol EP Impurity K) structure
EPK
碘海醇杂质11(碘海醇EP杂质K)Iohexol Impurity 11(Iohexol EP Impurity K)
Iohexol Impurity 11(Iohexol EP Impurity K)
CAS No.35453-19-1
Chemical FormulaC8H4I3NO4
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 12(Iohexol EP Impurity L) structure
EPL
碘海醇杂质12(碘海醇EP杂质L)Iohexol Impurity 12(Iohexol EP Impurity L)
Iohexol Impurity 12(Iohexol EP Impurity L)
CAS No.37441-29-5
Chemical FormulaC8H2Cl2I3NO2
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 14(Iohexol EP Impurity N) structure
EPN
碘海醇杂质14(碘海醇EP杂质N)Iohexol Impurity 14(Iohexol EP Impurity N)
Iohexol Impurity 14(Iohexol EP Impurity N)
CAS No.2730989-02-1
Chemical FormulaC21H28I3N3O10
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 15(Iohexol EP Impurity O) structure
EPO
碘海醇杂质15(碘海醇EP杂质O)Iohexol Impurity 15(Iohexol EP Impurity O)
Iohexol Impurity 15(Iohexol EP Impurity O)
CAS No.2725999-26-6
Chemical FormulaC21H28I3N3O10
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 18 (Iohexol USP Related Compound C) structure
USPC
碘海醇杂质18 (碘海醇USP相关化合物C)Iohexol Impurity 18 (Iohexol USP Related Compound C)
Iohexol Impurity 18 (Iohexol USP Related Compound C)
CAS No.76820-34-3
Chemical FormulaC14H19N3O8
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 20 structure
20
碘海醇杂质20Iohexol Impurity 20
Iohexol Impurity 20
CAS No.1215856-35-1
Chemical FormulaC14H19I2N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 22 structure
22
碘海醇杂质22Iohexol Impurity 22
Iohexol Impurity 22
CAS No.76801-94-0
Chemical FormulaC22H26I3N3O10
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 24 structure
24
碘海醇杂质24Iohexol Impurity 24
Iohexol Impurity 24
CAS No.111453-32-8
Chemical FormulaC11H11I3N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 26 structure
26
碘海醇杂质26(混合酯交换物)Iohexol Impurity 26
Iohexol Impurity 26
CAS No.2243186-05-0
Chemical FormulaC14H19N3O8
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 27 structure
27
碘海醇杂质27(混合酯还原物)Iohexol Impurity 27
Iohexol Impurity 27
CAS No.267881-77-6
Chemical FormulaC14H21N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 28 structure
28
碘海醇杂质28(混合酯碘化物)Iohexol Impurity 28
Iohexol Impurity 28
CAS No.1096689-22-3
Chemical FormulaC14H18I3N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 30 structure
30
碘海醇杂质30Iohexol Impurity 30
Iohexol Impurity 30
CAS No.606-17-7
Chemical FormulaC20H14I6N2O6
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 31 structure
31
碘海醇杂质31Iohexol Impurity 31
Iohexol Impurity 31
CAS No.99139-36-3
Chemical FormulaC18H24I3N3O9
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 32 structure
32
碘海醇杂质32Iohexol Impurity 32
Iohexol Impurity 32
CAS No.2493974-90-4
Chemical FormulaC19H26I3N3O9
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 33 structure
33
碘海醇杂质33Iohexol Impurity 33
Iohexol Impurity 33
CAS No.1150307-23-5
Chemical FormulaC19H27I3N4O8
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 34 structure
34
碘海醇杂质34Iohexol Impurity 34
Iohexol Impurity 34
CAS No.56562-80-2
Chemical FormulaC18H24I3N3O9
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 35 structure
35
碘海醇杂质35Iohexol Impurity 35
Iohexol Impurity 35
CAS No.31105-23-4
Chemical FormulaC19H26I3N3O9
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 40 structure
40
碘海醇杂质40Iohexol Impurity 40
Iohexol Impurity 40
CAS No.1404062-34-5
Chemical FormulaC19H26I3N3O9
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 42 structure
42
碘海醇杂质42Iohexol Impurity 42
Iohexol Impurity 42
CAS No.7423-53-2
Chemical FormulaC12H18Cl3N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 43 structure
43
碘海醇杂质43Iohexol Impurity 43
Iohexol Impurity 43
CAS No.76350-23-7
Chemical FormulaC16H20I3N3O7
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 45 structure
45
碘海醇杂质45Iohexol Impurity 45
Iohexol Impurity 45
CAS No.105737-94-8
Chemical FormulaC18H22I3N3O8
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 46 structure
46
碘海醇杂质46Iohexol Impurity 46
Iohexol Impurity 46
CAS No.76820-35-4
Chemical FormulaC14H21N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 51 structure
51
碘海醇杂质51Iohexol Impurity 51
Iohexol Impurity 51
CAS No.219851-73-7
Chemical FormulaC8Cl2I3NO3S
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 52 structure
52
碘海醇杂质52Iohexol Impurity 52
Iohexol Impurity 52
CAS No.2253945-66-1
Chemical FormulaC17H24I3N3O8
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 54 structure
54
碘海醇杂质54Iohexol Impurity 54
Iohexol Impurity 54
CAS No.1651211-78-7
Chemical FormulaC19H27I2N3O9
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 55 structure
55
碘海醇杂质55Iohexol Impurity 55
Iohexol Impurity 55
CAS No.37938-54-8
Chemical FormulaC8H4I3NO4
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 57 structure
57
碘海醇杂质57Iohexol Impurity 57
Iohexol Impurity 57
CAS No.2229906-00-5
Chemical FormulaC19H24I3N3O8
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 62 structure
62
碘海醇杂质62Iohexol Impurity 62
Iohexol Impurity 62
CAS No.1609479-72-2
Chemical FormulaC32H38I6N6O13
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 65 structure
65
碘海醇杂质65Iohexol Impurity 65
Iohexol Impurity 65
CAS No.2657760-44-4
Chemical FormulaC22H32I3N3O11
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 66 structure
66
碘海醇杂质66Iohexol Impurity 66
Iohexol Impurity 66
CAS No.162321-54-2
Chemical FormulaC8H2I4O4
Purity>95%询价On request
10mg25mg50mg100mg
Iohexol Impurity 67 structure
67
碘海醇杂质67Iohexol Impurity 67
Iohexol Impurity 67
CAS No.3094096-09-7
Chemical FormulaC7H2I4O3
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

碘海醇 —— 研究文献与合成路线Iohexol — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 碘海醇 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Iohexol. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Kinetics and model development of iohexol degradation during UV/H2O2 and UV/S2O82- oxidation
    Hu CY, Hou YZ, Lin YL, et al. · Chemosphere · 2019 · 被引 14cited 14
  2. Quality by Design approach in the development of hydrophilic interaction liquid chromatographic method for the analysis of iohexol and its impurities
    Jovanović M, Rakić T, Tumpa A, et al. · Journal of pharmaceutical and biomedical analysis · 2015 · 被引 15cited 15

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR THE MANUFACTURE OF IOHEXOL
    GALINDRO JOSE, MARTO SUSANA, BANDARRA JOAO ANTONIO MOINHO, HEGGIE WILLIAM · 公开号 KR20090004842KR20090004842 · 2009
  2. Process for the manufacture of iohexol
    MOINHO BANDARRA JOAO ANTONIO, WILLIAM HEGGIE, JOSE GALINDRO, SUSANNA MARTO · 公开号 ZA200804421ZA200804421 · 2009
  3. Process for iohexol manufacture
    YE SHUXIANG CHEN · 公开号 CN1907961CN1907961 · 2007
  4. PROCESS FOR THE MANUFACTURE OF IOHEXOL
    GALINDRO JOSE, MARTO SUSANA, BANDARRA JOAO ANTONIO MOINHO, HEGGIE WILLIAM · 公开号 WO2007060380WO2007060380 · 2007
  5. Process for the manufacture of iohexol
    GALINDRO JOSE, MARTO SUSANA, BANDARRA JOAO, HEGGIE WILLIAM · 公开号 US7541494US7541494 · 2009

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

碘海醇 杂质谱研究要点Iohexol — impurity profiling notes

下面这些是拿到 碘海醇 的 33 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 33 impurity entries for Iohexol, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances